• Home
• Partneringtools
• Reports

• In-licensing
• Out-licensing
• Companies

• Articles
• Events
• Outsourcing

• Consulting
• Jobs
• Forums

• About us
• Products
• Newsletter

Pharmalicensing Ltd
is a division of

News of the day

Industry news search

Recent news

To keep up to date with news from this category use our

MiddleBrook Pharmaceuticals Reports First Quarter 2008 Results
GERMANTOWN, Md., May 13, 2008 -- MiddleBrook Pharmaceuticals, Inc. (Nasdaq: MBRK), a pharmaceutical company focused on developing and commercializing novel anti-infective products, today announced financial and...

ThromboGenics is today issuing a business update for the three month period ended 31 March 2008...
Leuven, Belgium - May 13, 2008 (after closing of the markets) - ThromboGenics NV (Euronext Brussels: THR), a biotechnology company focused on innovative treatments for vascular disease, eye disease and cancer, is today...

Neurologix Announces First Quarter 2008 Financial Results
FORT LEE, N.J.--May 12, 2008--Neurologix, Inc. (OTCBB:NRGX), a biotechnology company engaged in the development of innovative gene therapies for the brain and central nervous system, announced today its financial...

Titan Pharmaceuticals Announces First Quarter 2008 Financial Results
SOUTH SAN FRANCISCO, Calif.--May 12, 2008--Titan Pharmaceuticals, Inc. (AMEX:TTP) today reported financial results for the first quarter ended March 31, 2008.

DRAXIS Health Reports Results for the First Quarter of 2008
MONTREAL, QUEBEC, May 9, 2008 - DRAXIS Health Inc. (TSX: DAX) (NASDAQ: DRAX) reported first quarter financial results for the three months ended March 31, 2008. Revenues and earnings for the first quarter of 2008 were...

PLIVA Announces Q1 2008 Results
May 09, 2008--PLIVA d.d. (LSE: PLVD, ZSE: PLVA-R-A), a subsidiary of Barr Pharmaceuticals, Inc. ("Barr"), today reported financial results for the three month period ended 31 March 2008, prepared in accordance with...

SemBioSys announces first quarter 2008 financial and operational results
CALGARY, May 9 - SemBioSys Genetics Inc. (TSX:SBS), a biotechnology company developing a portfolio of therapeutic proteins for metabolic and cardiovascular diseases, today announced its 2008 first quarter operational...

NOVAVAX REPORTS FIRST QUARTER 2008 FINANCIAL RESULTS
ROCKVILLE, MD (May 9, 2008) -- Novavax, Inc. (NASDAQ: NVAX) today announced financial results for the first quarter 2008. Novavax reported a net loss of $7.8 million ($0.13 loss per share) for the first quarter of 2008...

Aeolus Pharmaceuticals Announces Second Quarter Fiscal Year 2008 Financial Results
Laguna Niguel, California, May 9, 2008 -- Aeolus Pharmaceuticals, Inc. (OTC Bulletin Board: AOLS) announced today financial results for the three months ended March 31, 2008. The Company reported a net loss of $697,000,...

Alpharma Files Form 10-Q for the Three Months Ended March 31, 2008
Bridgewater, NJ...May 9, 2008...Alpharma Inc. (NYSE:ALO), a global specialty pharmaceutical company, today announced the filing of its Form 10-Q for the quarter ended March 31, 2008. First quarter 2008 results include a...

Keryx Biopharmaceuticals, Inc. Announces First Quarter 2008 Financial Results
NEW YORK, May 9 -- Keryx Biopharmaceuticals, Inc. (Nasdaq: KERX), a biopharmaceutical company focused on the acquisition, development and commercialization of medically important, novel pharmaceutical products for the...

Therapeutic DNA Vaccine Company Inovio Biomedical Reports First Quarter 2008 Financial Results
SAN DIEGO--May 9, 2008--Inovio Biomedical Corporation (AMEX: INO) ("Inovio") today reported financial results for the quarter ended March 31, 2008.

Eurand Reports First Quarter 2008 Key Achievements and Financial Results
Amsterdam - May 9, 2008 - Eurand N.V. (NASDAQ: EURX), a specialty pharmaceutical company that develops enhanced pharmaceutical and biopharmaceutical products based on its proprietary drug formulation technologies, today...

Cyclacel Pharmaceuticals announces first quarter 2008 financial results
BERKELEY HEIGHTS, NJ - May 9, 2008 - Cyclacel Pharmaceuticals, Inc. (NASDAQ: CYCC, NASDAQ: CYCCP) announced today financial and operating results for the first quarter of 2008. The Company's net loss for the quarter was...

LAB Research Announces its 2008 First Quarter Financial Results
Laval, Quebec, May 8, 2008 - LAB Research Inc. (TSX: LRI) ("LAB Research" or the "Company"), a Canadian-based global non-clinical contract research organization, announced today its 2008 first quarter financial results.

Acusphere, Inc. Reports Q1 2008 Financial Results and Business Highlights
WATERTOWN, Mass., May 08, 2008 -- Acusphere, Inc. (NASDAQ: ACUS) today reported financial results for the first quarter ended March 31, 2008 and commented on its financial results and business highlights.

DJO Incorporated Announces Financial Results For First Quarter 2008
SAN DIEGO, CA, May 8, 2008 - DJO Incorporated (formerly named ReAble Therapeutics, Inc.) ("DJO" or the "Company"), a global provider of medical devices that provide solutions for musculoskeletal health, vascular health...

TELIK ANNOUNCES FIRST QUARTER 2008 FINANCIAL RESULTS
Palo Alto, CA, May 8, 2008 - Telik, Inc. (Nasdaq: TELK) today reported a net loss of $9.8 million, or $0.19 per share, for the first quarter ended March 31, 2008, compared with a net loss of $16.3 million, or $0.31 per...

J. B. Chemicals & Pharmaceuticals Limited Announces Audited Financial Results for FY 2007-08
Mumbai, May 08, 2008: J. B. Chemicals & Pharmaceuticals Limited (JBCPL) today announced its Audited Financial Results for the Financial Year ended March 31, 2008.

Artes Medical to Announce First Quarter 2008 Financial Results
SAN DIEGO, May 08, 2008 -- Artes Medical, Inc. (Nasdaq:ARTE), a medical technology company whose product ArteFill(R) is the first and only FDA-approved non-resorbable injectable dermal filler for the correction of...

Adaltis Announces First Quarter Financial Results
MONTREAL, QUEBEC--(May 8, 2008) - Adaltis Inc. (TSX:ADS), an international in vitro diagnostic (IVD) company, today reported its first quarter 2008 financial results and the formal closing of the sale of its European...

PRELIMINARY RESULTS ANNOUNCEMENT for the year ended 31 December 2007
London, 08 May 2008 --ImmuPharma PLC (LSE:IMM), ("ImmuPharma" or the "Company"), the specialist drug discovery and development company, is pleased to announce its preliminary results for the year ended 31 December 2007.

West Announces First Quarter 2008 Results
LIONVILLE, Pa., May 1 2008-- West Pharmaceutical Services, Inc. (NYSE: WST) today announced results for the first quarter of 2008. Reported results included net after-tax benefits of $1.3 million, or $0.04 per diluted...

Achillion Reports First Quarter 2008 Financial Results
NEW HAVEN, Conn., May 7, 2008 -- Achillion Pharmaceuticals, Inc. (Nasdaq:ACHN), a leader in the discovery and development of small molecule drugs to combat the most challenging infectious diseases, today reported...

Quarterly review, first quarter
May 07, 2008--William Demant Holding--It is estimated that in the past part of 2008, the global hearing aid market has seen growth in the lower part of the Group's long-term expectations of 2-4% unit growth. The Company...

CSP Inc. Announces Second-Quarter Fiscal 2008 Financial Results
BILLERICA, MA, May 7, 2008 - CSP Inc. (NASDAQ: CSPI), a provider of IT solutions, systems integration services and dense cluster computing systems, today reported financial results for the three and six months ended...

Interim Report January-March 2008
May 7, 2008 -- Period in brief · Net revenues amounted to MSEK 24.0 (6.4) · The loss after tax was MSEK 62.2 (loss: 37.9) · Earnings per share amounted to a loss of SEK 2.88 (loss: 2.73)

Interim report for the first quarter of 2008 - strong growth in sales and profits
May 07, 2008 -- Lundbeck's interim report for the first quarter of 2008 shows continuing strong growth in consolidated revenue distributed on the company's new products as well as on the regions. Lundbeck retains its...

VALEANT PHARMACEUTICALS REPORTS 2008 FIRST QUARTER FINANCIAL RESULTS
ALISO VIEJO, Calif., May 7, 2008 - Valeant Pharmaceuticals International (NYSE:VRX) today announced first quarter financial results for 2008.

The results for Q1 2008 - Sales growth in the infectious diseases segment
7 May 2008: NorDiag had operating revenues of NOK 3.4 million and other revenues of NOK 1.1 million in Q1-08, compared to NOK 1.6 million and NOK 0.7 million in same quarter 2007. In Q4-07, the operating revenue was NOK...

Emisphere Technologies, Inc. Announces 2008 First Quarter Financial Results
CEDAR KNOLLS, N.J., May 7, 2008 -- Emisphere Technologies, Inc. (Nasdaq: EMIS) today announced its financial results for the first quarter ended March 31, 2008.

Enzon Reports Strong First Quarter 2008 Results
BRIDGEWATER, N.J., May 07, 2008 -- Enzon Pharmaceuticals, Inc. (Nasdaq: ENZN) today announced strong first quarter 2008 financial results. For the three months ended March 31, 2008, Enzon reported a net income of $1.5...

Threshold Pharmaceuticals Reports First Quarter 2008 Financial Results
REDWOOD CITY, Calif., May 7, 2008 -- Threshold Pharmaceuticals, Inc. (Nasdaq:THLD) today reported financial results for the first quarter ended March 31, 2008.

STERIS Corporation Announces Fiscal 2008 Fourth Quarter and Full Year Results
MENTOR, Ohio, May 7 2008 - STERIS Corporation (NYSE: STE) today announced financial results for its fiscal 2008 fourth quarter ended March 31, 2008. Fiscal 2008 fourth quarter revenues increased 7% to $375.2 million...

SORIN GROUP ANNOUNCES EARNINGS FOR Q1-2008 EXCEEDING GUIDANCE. FULL YEAR GUIDANCE CONFIRMED
Milan, May 7, 2008 - The Board of Directors of Sorin S.p.A. meeting today under the chairmanship of Umberto Rosa, approved the consolidated financial statements for the first quarter of 2008, ending March 31st.

Solutia Announces First Quarter 2008 Results
ST. LOUIS, May 7, 2008 -- Solutia Inc. (NYSE:SOA) today reported net sales of $985 million for the first quarter of 2008, a 40% increase over net sales of $702 million for the same period in 2007. Approximately 29% of...

Salix Pharmaceuticals Reports 1Q2008 Results
RALEIGH, NC, May 6, 2008 - Salix Pharmaceuticals, Ltd. (NASDAQ:SLXP) today announced financial and operating results for the first quarter ended March 31, 2008.

Cadence Pharmaceuticals Reports First Quarter 2008 Financial Results and Provides Clinical Program Update
SAN DIEGO, May 6, 2008 -- Cadence Pharmaceuticals, Inc. (Nasdaq: CADX), a biopharmaceutical company focused on in-licensing, developing and commercializing proprietary product candidates principally for use in the...

Discovery Labs Reports First Quarter 2008 Financial Results
Warrington, PA -- May 6, 2008 -- Discovery Laboratories, Inc. (Nasdaq: DSCO) today announced financial results for the first quarter ended March 31, 2008. For the quarter ended March 31, 2008, the Company reported a net...

Covidien Reports Second-Quarter 2008 Results
HAMILTON, Bermuda, May 06, 2008 -- Covidien Ltd. (NYSE: COV; BSX: COV) today reported results for the second quarter of fiscal 2008 (January - March 2008). Second-quarter net sales rose 10% to $2.4 billion from $2.2...

Poniard Pharmaceuticals Reports First Quarter 2008 Financial Results and Corporate Update
SOUTH SAN FRANCISCO, Calif., May 6, 2008 -- Poniard Pharmaceuticals, Inc. (Nasdaq: PARD), a biopharmaceutical company focused on oncology, today reported on its corporate progress and financial results for the first...

NMT Medical, Inc (NMTI) Announces First-Quarter 2008 Financial Results
May 06, 2008 -- BOSTON-- NMT Medical, Inc. (NASDAQ: NMTI), an advanced medical technology company that designs, develops, manufactures and markets proprietary implant technologies that allow interventional cardiologists...

NeuroMetrix, Inc. Reports Total Revenues of $9.1 Million for the First Quarter of 2008, Decrease of 23% from the First Quarter of 2007; Cash and Investment Position of $26.6 Million
WALTHAM, Mass.-- May 6, 2008--NeuroMetrix, Inc. (Nasdaq: NURO), a medical device company advancing patient care through the development and marketing of innovative medical device products that aid physicians in the...

Myriad Genetics Reports Results for Third Quarter of Fiscal 2008
SALT LAKE CITY, UT, May 06, 2008 -- Myriad Genetics, Inc. (NASDAQ: MYGN) (www.myriad.com) today reported consolidated financial results for the third quarter of fiscal 2008 and the nine months ended March 31, 2008.

OraSure Technologies Announces 2008 First Quarter Results
BETHLEHEM, Pa., May 06, 2008 -- OraSure Technologies, Inc. (NASDAQ:OSUR), a market leader in oral fluid diagnostics, today announced quarterly revenues of $18.1 million for the three months ended March 31, 2008,...

Onyx Pharmaceuticals Reports 2008 First Quarter Results
EMERYVILLE, Calif. -- May 06, 2008 - Onyx Pharmaceuticals, Inc. (Nasdaq: ONXX) today reported its financial results for the first quarter ended March 31, 2008. Onyx reported net income of $15.4 million, or $0.27 per...

Ferro Reports First-Quarter 2008 Results
CLEVELAND--May 6, 2008--Ferro Corporation (NYSE: FOE) announced today that sales for the three months ended March 31, 2008 were a record $607.2 million, up 15 percent from the first quarter of 2007.

CombinatoRx Reports Financial Results for the First Quarter 2008
CAMBRIDGE, Mass., May 06, 2008 -- CombinatoRx, Incorporated (NASDAQ: CRXX), today reported financial results for the first quarter ended March 31, 2008.

Maxygen Reports First Quarter 2008 Financial Results
REDWOOD CITY, Calif., May 6, 2008 -- Maxygen, Inc. (Nasdaq: MAXY), a biotechnology company focused on the development of improved protein drugs, today reported financial results and business milestones for the quarter...

Cutera Reports First Quarter 2008 Results
BRISBANE, Calif., May 6, 2008 -- Cutera, Inc. (NASDAQ: CUTR), a leading provider of laser and other light-based aesthetic systems for practitioners worldwide, today reported financial results for the first quarter ended...

Cutera Reports First Quarter 2008 Results
BRISBANE, Calif., May 6, 2008 -- Cutera, Inc. (NASDAQ: CUTR), a leading provider of laser and other light-based aesthetic systems for practitioners worldwide, today reported financial results for the first quarter ended...

Charles River Announces First-Quarter 2008 Results
WILMINGTON, Mass., May 06, 2008-- Charles River Laboratories International, Inc. (NYSE: CRL) today reported its results for the first quarter of 2008. For the quarter, net sales increased 16.0% to $337.7 million from...

CONCEPTUS® REPORTS FIRST QUARTER NET SALES UP 53%
MOUNTAIN VIEW, Calif. (May 6, 2008) - Conceptus, Inc. (NASDAQ: CPTS), developer of the Essure® procedure, the first and only non-incisional permanent birth control method available, today reported financial results for...

ZymoGenetics Reports First Quarter 2008 Financial Results
SEATTLE, May 06, 2008 -- ZymoGenetics, Inc. (NASDAQ:ZGEN), today reported its financial results for the first quarter ended March 31, 2008. The company reported a net loss of $40.9 million, or $0.60 per share, compared...

Lumera Reports First Quarter 2008 Results and Updates Revenue Expectations
BOTHELL, Wash., May 06, 2008 -- Lumera Corporation (NASDAQ:LMRA), a leader in photonics communication, today reported financial results for the first quarter 2008.

Targacept Reports First Quarter 2008 Financial Results
May 06, 2008 -- Targacept, Inc. (NASDAQ: TRGT), a clinical-stage biopharmaceutical company developing a new class of drugs known as NNR Therapeutics(TM), today reported its financial results for the first quarter ended...

TEVA REPORTS FIRST QUARTER 2008 RESULTS
Jerusalem, Israel, May 6, 2008 - Teva Pharmaceutical Industries Ltd. (NASDAQ: TEVA) today reported results for the quarter ended March 31, 2008.

Isotechnika reports first quarter financial results
EDMONTON, May 6, 2008 - Isotechnika Inc. announced today its financial results for the first quarter ended March 31, 2008 and provided a review of the Company's operational and scientific progress for the quarter.

ATRIUM SHOWS A STRONG FINANCIAL PERFORMANCE FOR ITS FIRST QUARTER
Quebec (Quebec), May 6, 2008 - Atrium Innovations Inc. (TSX: ATB), a recognized leading developer, manufacturer and marketer of added value products for health and nutrition industries, announced today his financial...

SOMAXON PHARMACEUTICALS REPORTS 2008 FIRST QUARTER FINANCIAL RESULTS
SAN DIEGO, CA - May 6, 2008 - Somaxon Pharmaceuticals, Inc. (Nasdaq: SOMX), a specialty pharmaceutical company focused on the in-licensing and development of proprietary product candidates for the treatment of diseases...

STAAR Surgical Reports Solid First Quarter Progress
MONROVIA, Calif., May 6 -- STAAR Surgical Company (Nasdaq: STAA), a leading developer, manufacturer and marketer of minimally invasive ophthalmic products, today reported good progress during its first quarter ended...

StemCells Announces 2008 First Quarter Results
PALO ALTO, Calif., May 6, 2008 , - StemCells, Inc. (NASDAQ: STEM) today reported its financial results for the first quarter ended March 31, 2008.

Stereotaxis Reports Record First Quarter Orders
ST. LOUIS, May 6 -- Stereotaxis, Inc. (Nasdaq: STXS) today reported results for the quarter ended March 31, 2008. Despite the continued unavailability of a partner's magnetic irrigated catheter, revenue for the first...

Rigel Announces First Quarter 2008 Financial Results
SOUTH SAN FRANCISCO, Calif. - May 06, 2008 -- Rigel Pharmaceuticals, Inc. (Nasdaq:RIGL) today reported financial results for the first quarter ended March 31, 2008.

RTI Biologics Announces 2008 First Quarter Results
ALACHUA, Fla. (May 6, 2008) - RTI Biologics Inc. (RTI) (Nasdaq: RTIX), a leading processor of orthopedic and other biologic implants, announced today that the company's revenues were $29.9 million for the first quarter...

Recordati: positive first quarter 2008 results, sales and income increase
Milan, 6 May 2008 - The Board of Directors of Recordati S.p.A. approved the Group's consolidated results for the first quarter 2008 prepared in accordance with International Accounting Standards and International...

More moderate growth for PULSION in first quarter
Munich, May 06, 2008 - PULSION Medical Systems AG, a life science corporation specializing in medical diagnostic and therapy systems, listed on the Prime Standard of the Frankfurt Stock Exchange, increased its...

Henry Schein Reports Record First Quarter Results
MELVILLE, N.Y.-- May 6, 2008--Henry Schein, Inc. (NASDAQ: HSIC), the largest provider of healthcare products and services to office-based practitioners in the combined North American and European markets, today reported...

Greatbatch, Inc. Reports First Quarter 2008 Results
CLARENCE, N.Y.-- May 6, 2008--Greatbatch, Inc. (the "Company") (NYSE: GB) today reported its results for the first quarter ended March 28, 2008.

Genomic Health Announces First Quarter 2008 Financial Results and Business Progress
REDWOOD CITY, Calif., May 6, 2008 -- Genomic Health, Inc. (Nasdaq: GHDX) today reported financial results and business progress for the quarter ended March 31, 2008.

AMRI Announces First Quarter 2008 Results
Albany, NY (May 5, 2008) -- AMRI (NASDAQ: AMRI) today reported financial and operating results for the first quarter ended March 31, 2008.

McKesson Reports Fiscal 2008 Fourth-Quarter and Full-Year Results
May 05, 2008 -- SAN FRANCISCO-- McKesson Corporation (NYSE:MCK) today reported that revenues for the fourth quarter ended March 31, 2008 were $26.2 billion compared to $24.2 billion a year ago. Fourth-quarter earnings...

BELLUS HEALTH reports results for first quarter of fiscal 2008
LAVAL, QC, May 5 - BELLUS Health Inc. (NASDAQ: BLUS; TSX: BLU, formerly known as Neurochem Inc.) reported results for the first quarter ended March 31, 2008. The Company reported a net loss of $12,902,000 ($0.26 per...

MannKind Corporation Reports First Quarter Financial Results
VALENCIA, Calif., May 5, 2008 -- MannKind Corporation (Nasdaq: MNKD) today reported financial results for the first quarter ended March 31, 2008.

Tredegar Reports First-Quarter Results
RICHMOND, Va., May 5, 2008 -- Tredegar Corporation (NYSE: TG) reported first-quarter net income from continuing operations of $3.8 million (11 cents per share) compared to $11.1 million (28 cents per share) in the first...

ATS Medical Announces Record Quarterly Revenue and Gross Profit
MINNEAPOLIS, May 5-- ATS Medical, Inc. (Nasdaq: ATSI), manufacturer and marketer of state-of-the-art cardiac surgery products and services, today reported financial results for the first quarter ended March 29, 2008....

ImmuCell Announces Financial Results for First Quarter of 2008
PORTLAND, ME - May 5, 2008 - ImmuCell Corporation (NASDAQ Capital Market: ICCC) today announced the results of its operations for the three-month period ended March 31, 2008.

SRI Surgical Reports First Quarter 2008 Financial Results
TAMPA, Fla., May 5, 2008 -- SRI/Surgical Express, Inc. (Nasdaq:STRC), a leading provider of reusable surgical device reprocessing services supporting the healthcare industry, today announced financial results for the...

HUMAN GENOME SCIENCES ANNOUNCES FIRST QUARTER 2008 FINANCIAL RESULTS AND KEY DEVELOPMENTS
ROCKVILLE, Maryland - May 5, 2008 - Human Genome Sciences, Inc. (Nasdaq: HGSI) today announced financial results and key developments for the quarter ended March 31, 2008.

Acorda Therapeutics Reports First Quarter 2008 Financial Results
HAWTHORNE, N.Y., May 05, 2008 -- Acorda Therapeutics, Inc. (Nasdaq: ACOR) today announced its financial results for the first quarter 2008.

EntreMed Reports First Quarter 2008 Financial Results
ROCKVILLE, Md., May 2, 2008 - EntreMed, Inc.-- (Nasdaq: ENMD), a clinical-stage pharmaceutical company developing therapeutics for the treatment of cancer and inflammatory diseases, today reported financial results for...

SCOLR Pharma, Inc. Reports First Quarter 2008 Financial Results
BELLEVUE, Wash.-May 2, 2008-SCOLR Pharma, Inc. (AMEX: DDD - News) today reported financial results for the three months ended March 31, 2008. The Company will host a live conference call today, May 2, 2008, at 11:30...

IMPAX Continues to Make Progress in Filing Delinquent Periodic Reports
HAYWARD, Calif., May 02, 2008 -- IMPAX Laboratories, Inc. (OTC:IPXL) today announced that it continues to make progress towards filing its 2004 through 2007 delinquent financial reports with the Securities and Exchange...

I-Flow Reports 18% Increase in Regional Anesthesia Sales for the First Quarter of 2008 to $22.6 Million Versus $19.1 Million for the First Quarter of 2007
LAKE FOREST, Calif.-- May 2, 2008--I-Flow Corporation (NASDAQ:IFLO) announced today that Regional Anesthesia revenues increased 18% for the first quarter of 2008 to a first quarter record $22.6 million compared to $19.1...

GeneNews (GEN.TO) Announces First Quarter Results
TORONTO, May 2, 2008 - GeneNews Limited , a company focused on developing blood-based biomarker tests for the early detection of diseases and personalized health management, today reported operational and financial...

Penwest Reports First Quarter 2008 Financial Results
DANBURY, Conn., May 2, 2008 -- Penwest Pharmaceuticals Co. (Nasdaq:PPCO) today announced its financial results for the first quarter ended March 31, 2008.

Depomed Reports First Quarter 2008 Financial Results
MENLO PARK, Calif.--May 1, 2008--Depomed, Inc. (NASDAQ: DEPO) today reported financial results for the first quarter ended March 31, 2008.

TYCO INTERNATIONAL REPORTS SECOND QUARTER EARNINGS FROM CONTINUING OPERATIONS OF $0.67 PER SHARE BEFORE SPECIAL ITEMS AND GAAP EARNINGS OF $0.56 PER SHARE
PEMBROKE, Bermuda - May 1, 2008 - Tyco International Ltd. (NYSE: TYC; BSX: TYC) today reported $0.56 in diluted earnings per share (EPS) from continuing operations for the fiscal second quarter of 2008 and diluted EPS...

OSI Systems Reports Third Quarter Fiscal 2008 Financial Results
May 01, 2008 -- OSI Systems, Inc. (NASDAQ:OSIS), a vertically integrated provider of specialized electronics products for critical applications in the Security and Healthcare industries, today announced financial...

CIPHER REPORTS FIRST QUARTER FISCAL 2008 RESULTS
MISSISSAUGA, Ontario, May 1, 2008 - Cipher Pharmaceuticals Inc. (TSX: DND) today announced its financial and operational results for the three months ended March 31, 2008.

United Therapeutics Reports First Quarter 2008 Financial Results
SILVER SPRING, Md., May 1, 2008 -- United Therapeutics Corporation (Nasdaq: UTHR) today announced its results of operations for the quarter ended March 31, 2008.

LA JOLLA PHARMACEUTICAL COMPANY REPORTS FIRST QUARTER FINANCIAL RESULTS
SAN DIEGO, MAY 1, 2008 -- La Jolla Pharmaceutical Company (Nasdaq: LJPC) reported a net loss for the three months ended March 31, 2008 of $13.6 million, or $0.34 per share (on 39.6 million weighted-average shares),...

ImmunoGen, Inc. Reports Third Quarter Fiscal Year 2008 Financial Results
WALTHAM, Mass.- May 1, 2008--ImmunoGen, Inc. (Nasdaq: IMGN), a biopharmaceutical company that develops targeted anticancer therapeutics using its Tumor-Activated Prodrug (TAP) technology, today announced financial...

Thoratec Reports 12 Percent Increase in First Quarter Revenues
PLEASANTON, Calif., May 1, 2008 -- Thoratec Corporation (Nasdaq: THOR), a world leader in device-based mechanical circulatory support therapies to save, support and restore failing hearts, today reported record...

HBIO Reports First Quarter 2008 Revenue Growth of 15%
HOLLISTON, Mass., May 01, 2008 -- Harvard Bioscience, Inc. (Nasdaq: HBIO), a global developer, manufacturer, and marketer of a broad range of tools to advance life science research, today reported unaudited financial...

Cerus Corporation Announces First Quarter Financial Results
CONCORD, Calif.--May 1, 2008--Cerus Corporation (NASDAQ:CERS) today announced financial results for the first quarter ended March 31, 2008.

Palomar Medical Reports Financial Results for First Quarter 2008
BURLINGTON, Mass., May 1, 2008 -- Palomar Medical Technologies, Inc. (Nasdaq: PMTI), a leading researcher and developer of light-based systems for cosmetic treatments, today announced financial results for the first...

Industry news: Pharmalicensing provides comprehensive industry coverage.

Products:	Partnering Consulting	Partnering Search	Company Profiling	Comparision	Partneringtools	Reports
In-licensing:	Latest records	Industry Sector	Therapeutic Target	Search	Profile your company	Pharma partnering
Out-licensing:	Latest records	Industry Sector	Therapeutic Target	Search	Profile your company	Pharma partnering
Companies:	Profiled companies	Industry Sector	Therapeutic Target	Geographic Location	Search	Add your company
Reports:	Biotechnology	Business Development	Management	Market & Sales	Medical Devices	Pharmaceuticals
Jobs:	Pharmaceutical jobs	Browse jobs	Search for jobs	Create your CV	Employer profiles	Post your jobs
Forums:	Talk to an expert	Industry Gossip	Business Development	What's new	Reports	Outsourcing
News:	Deals & Alliances	Development	Financial Results	Financings	Intellectual Property	Regulatory
Events:	Pharma events	Calendar	Organizers	Featured events	Search	Add your event
Articles:	Business Development	Technologies	Events	Legal and regulatory	Therapeutic	Post your article
Deals:	Industry Sector	Therapeutic Target	Deals Date	Search	Reports	Company releases
About us:	Our Audience	Case Studies	Newsletter	Careers	FAQ	Contact us